Search Results - "Archives of neurology (Chicago)"
-
1
Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China
Published in JAMA neurology (01-06-2020)“…The outbreak of coronavirus disease 2019 (COVID-19) in Wuhan, China, is serious and has the potential to become an epidemic worldwide. Several studies have…”
Get more information
Journal Article -
2
Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review
Published in JAMA neurology (01-08-2020)“…Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in December 2019, causing human coronavirus disease 2019 (COVID-19), which has now spread…”
Get more information
Journal Article -
3
Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease
Published in JAMA neurology (01-01-2022)“…The EMERGE and ENGAGE phase 3 randomized clinical trials of aducanumab provide a robust data set to characterize amyloid-related imaging abnormalities (ARIA)…”
Get more information
Journal Article -
4
Burden of Neurological Disorders Across the US From 1990-2017: A Global Burden of Disease Study
Published in JAMA neurology (01-02-2021)“…Accurate and up-to-date estimates on incidence, prevalence, mortality, and disability-adjusted life-years (burden) of neurological disorders are the backbone…”
Get more information
Journal Article -
5
Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis
Published in JAMA neurology (01-09-2020)“…Risk factors associated with the severity of coronavirus disease 2019 (COVID-19) in patients with multiple sclerosis (MS) are unknown. Disease-modifying…”
Get more information
Journal Article -
6
Neurologic Involvement in Children and Adolescents Hospitalized in the United States for COVID-19 or Multisystem Inflammatory Syndrome
Published in JAMA neurology (01-05-2021)“…Coronavirus disease 2019 (COVID-19) affects the nervous system in adult patients. The spectrum of neurologic involvement in children and adolescents is…”
Get more information
Journal Article -
7
Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum
Published in JAMA neurology (01-12-2021)“…Glial fibrillary acidic protein (GFAP) is a marker of reactive astrogliosis that increases in the cerebrospinal fluid (CSF) and blood of individuals with…”
Get more information
Journal Article -
8
Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials
Published in JAMA neurology (01-09-2020)“…Accumulation of disability in multiple sclerosis may occur as relapse-associated worsening (RAW) or steady progression independent of relapse activity (PIRA),…”
Get more information
Journal Article -
9
Worldwide Incidence of Aneurysmal Subarachnoid Hemorrhage According to Region, Time Period, Blood Pressure, and Smoking Prevalence in the Population: A Systematic Review and Meta-analysis
Published in JAMA neurology (01-05-2019)“…Subarachnoid hemorrhage (SAH) from ruptured intracranial aneurysms is a subset of stroke with high fatality and morbidity. Better understanding of a change in…”
Get more information
Journal Article -
10
Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease
Published in JAMA neurology (01-11-2021)“…Blood-based tests for brain amyloid-β (Aβ) pathology are needed for widespread implementation of Alzheimer disease (AD) biomarkers in clinical care and to…”
Get more information
Journal Article -
11
Neurologic and Radiographic Findings Associated With COVID-19 Infection in Children
Published in JAMA neurology (01-11-2020)“…Neurological manifestations have been reported in adults with coronavirus disease 2019 (COVID-19), which is caused by the highly pathogenic virus severe acute…”
Get more information
Journal Article -
12
Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies
Published in JAMA neurology (2020)“…Although highly effective disease-modifying therapies for multiple sclerosis (MS) have been associated with an increased risk of infections vs injectable…”
Get more information
Journal Article -
13
Clinical Significance of Magnetic Resonance Imaging Markers of Vascular Brain Injury: A Systematic Review and Meta-analysis
Published in JAMA neurology (01-01-2019)“…Covert vascular brain injury (VBI) is highly prevalent in community-dwelling older persons, but its clinical and therapeutic implications are debated. To…”
Get more information
Journal Article -
14
Magnetic Resonance Imaging Alteration of the Brain in a Patient With Coronavirus Disease 2019 (COVID-19) and Anosmia
Published in JAMA neurology (01-08-2020)Get more information
Journal Article -
15
Association of Chronic Active Multiple Sclerosis Lesions With Disability In Vivo
Published in JAMA neurology (01-12-2019)“…In multiple sclerosis (MS), chronic active lesions, which previously could only be detected at autopsy, can now be identified on susceptibility-based magnetic…”
Get more information
Journal Article -
16
Assessment of Endovascular Treatment for Acute Basilar Artery Occlusion via a Nationwide Prospective Registry
Published in JAMA neurology (01-05-2020)“…Several randomized clinical trials have recently established the safety and efficacy of endovascular treatment (EVT) of acute ischemic stroke in the anterior…”
Get more information
Journal Article -
17
Outcomes and Risk Factors Associated With SARS-CoV-2 Infection in a North American Registry of Patients With Multiple Sclerosis
Published in JAMA neurology (01-06-2021)“…Emergence of SARS-CoV-2 causing COVID-19 prompted the need to gather information on clinical outcomes and risk factors associated with morbidity and mortality…”
Get more information
Journal Article -
18
Estimating the Prevalence of Dementia and Mild Cognitive Impairment in the US: The 2016 Health and Retirement Study Harmonized Cognitive Assessment Protocol Project
Published in JAMA neurology (01-12-2022)“…Nationally representative data are critical for understanding the causes, costs, and outcomes associated with dementia and mild cognitive impairment (MCI) in…”
Get more information
Journal Article -
19
Global Prevalence and Incidence of Tinnitus: A Systematic Review and Meta-analysis
Published in JAMA neurology (01-09-2022)“…To date, no systematic review has taken a meta-analytic approach to estimating the prevalence and incidence of tinnitus in the general population. To provide…”
Get more information
Journal Article -
20
Global Prevalence of Young-Onset Dementia: A Systematic Review and Meta-analysis
Published in JAMA neurology (01-09-2021)“…Reliable prevalence estimates are lacking for young-onset dementia (YOD), in which symptoms of dementia start before the age of 65 years. Such estimates are…”
Get more information
Journal Article